One in Five Kids May ‘Outgrow’ Asthma – Newsday (subscription)

One in Five Kids May 'Outgrow' Asthma
Newsday (subscription)
"Sensitization to furred animals and a more severe asthma at age 7 to 8 years were both inversely associated with remission," said study author Dr. Martin Andersson, who is part of the Obstructive Lung Disease in Northern Sweden studies. Still, even
Allergies To Pets Linked To Persistence of Asthma As Children AgeMedical Daily
About One in Five Children Outgrow AsthmaMonthly Prescribing Reference

all 4 news articles »

View full post on asthma – Google News

Parents warned about asthma ‘epidemic’ when schools go back – The Times (subscription)

Parents warned about asthma 'epidemic' when schools go back
The Times (subscription)
Four times as many children are admitted to hospital with asthma attacks in September as at the start of the school holidays, analysis shows. Parents are being warned of a back-to-school asthma “timebomb” after figures revealed a mid-September peak for 

View full post on asthma – Google News

Controversial trade pacts threatening access to vital asthma medicines: expert – Shanghai Daily (subscription)

Controversial trade pacts threatening access to vital asthma medicines: expert
Shanghai Daily (subscription)
WELLINGTON, May 6 (Xinhua) — New international trade pacts, such as the under-negotiation Trans-Pacific Partnership (TPP), are putting access to quality medicines at risk for millions of asthma sufferers around the world, chair of the Global Asthma

and more »

View full post on asthma – Google News

Dupilumab Could End of Being ‘Blockbuster’ Asthma Drug – Analyst (SNY) (REGN) – StreetInsider.com (subscription)

Dupilumab Could End of Being 'Blockbuster' Asthma Drug – Analyst (SNY) (REGN)
StreetInsider.com (subscription)
Dupilumab may debut in 2018 as a treatment for skin and/or asthma conditions, Fernandez said. He observes the large market for asthma, with competition expected from the likes of AstraZenece (NYSE: AZN), GlaxoSmithKline (NYSE: GSK), and others.

View full post on asthma – Google News

BioLineRx’s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter … – PharmaLive (press release) (subscription)

BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter
PharmaLive (press release) (subscription)
BL-9010, a novel bi-specific antibody treatment for severe and persistent asthma, targets and links together two immunological modulators – IgE and CD300a. Allergen-bound IgE activates cells involved in allergic responses, such as mast cells, while

and more »

View full post on asthma – Google News

Local asthma hospitalizations lowest in state – The Herald-Times (subscription)


The Herald-Times (subscription)

Local asthma hospitalizations lowest in state
The Herald-Times (subscription)
From 2007 to 2011, Monroe County had the lowest reported rate of asthma hospitalizations in the state among 5- to 17-year-olds — and the state's third-lowest rate for emergency department visits by children suffering from asthma — according to

View full post on asthma – Google News

Stopping Controversial Asthma Drugs Could Have Downside: Study – Newsday (subscription)


Newsday (subscription)

Stopping Controversial Asthma Drugs Could Have Downside: Study
Newsday (subscription)
It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests. The U.S. Food and Drug Administration has warned that

View full post on asthma – Google News